These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12559253)

  • 1. Informed consent for prostate-specific antigen testing.
    Gann PH
    Urology; 2003 Jan; 61(1):5-6. PubMed ID: 12559253
    [No Abstract]   [Full Text] [Related]  

  • 2. Informed consent for prostate-specific antigen screening.
    Wilkinson S; Chodak G
    Urology; 2003 Jan; 61(1):2-4. PubMed ID: 12559252
    [No Abstract]   [Full Text] [Related]  

  • 3. Informed consent for prostate-specific antigen-based screening.
    Brawley OW
    Urology; 2003 Jan; 61(1):10-2. PubMed ID: 12559255
    [No Abstract]   [Full Text] [Related]  

  • 4. Informed consent for prostate-specific antigen screening.
    Catalona WJ
    Urology; 2003 Jan; 61(1):17-9. PubMed ID: 12559258
    [No Abstract]   [Full Text] [Related]  

  • 5. Informed consent for prostate-specific antigen screening.
    Carter HB
    Urology; 2003 Jan; 61(1):13-4. PubMed ID: 12559256
    [No Abstract]   [Full Text] [Related]  

  • 6. What patients should be told before agreeing to a blood test that could change their lives.
    Talcott JA
    Urology; 2003 Jan; 61(1):7-9. PubMed ID: 12559254
    [No Abstract]   [Full Text] [Related]  

  • 7. Informed consent for prostate-specific antigen-based screening--European view.
    Ito K; Schrder FH
    Urology; 2003 Jan; 61(1):20-2. PubMed ID: 12559259
    [No Abstract]   [Full Text] [Related]  

  • 8. Informed consent for prostate cancer screening--a call for equity in medical interventions.
    Thompson IM
    Urology; 2003 Jan; 61(1):15-6. PubMed ID: 12559257
    [No Abstract]   [Full Text] [Related]  

  • 9. [Legal (liability) aspects of PSA determination].
    Mielke K
    Urologe A; 2006 Jun; 45(6):756-65. PubMed ID: 16788794
    [No Abstract]   [Full Text] [Related]  

  • 10. What should men know about prostate-specific antigen screening before giving informed consent?
    Chan EC; Sulmasy DP
    Am J Med; 1998 Oct; 105(4):266-74. PubMed ID: 9809686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Making an informed choice about PSA screening.
    Ward J; Gattellari M
    Aust Fam Physician; 2001 Jul; 30(7):715-6. PubMed ID: 11558209
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening for prostate cancer. How can patients give informed consent?
    Marshall KG
    Can Fam Physician; 1993 Nov; 39():2385-90. PubMed ID: 7505673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific antigen testing for prostate cancer: the case for informed consent.
    McCredie M; Cox B
    Med J Aust; 1998 Jul; 169(1):9-10. PubMed ID: 9695692
    [No Abstract]   [Full Text] [Related]  

  • 14. Missing the mark on prostate-specific antigen screening.
    Miller DC; Hollenbeck BK
    JAMA; 2011 Dec; 306(24):2719-20. PubMed ID: 22203542
    [No Abstract]   [Full Text] [Related]  

  • 15. How can rates of prostate-specific antigen screening be reduced in men aged 80 and older?
    Whittle J; Zablocki CJ
    J Am Geriatr Soc; 2010 Apr; 58(4):757-9. PubMed ID: 20398158
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial panel on informed consent for PSA screening.
    Ramsden AR; Chodak G
    Urology; 2003 Sep; 62(3):589. PubMed ID: 12946782
    [No Abstract]   [Full Text] [Related]  

  • 17. Consent before testing men for prostate cancer--a challenge?
    Hirst G
    Aust Fam Physician; 2005 Oct; 34(10):888. PubMed ID: 16217582
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostate cancer screening--time to abandon one-size-fits-all approach?
    Kim J; Davis JW
    JAMA; 2011 Dec; 306(24):2717-8. PubMed ID: 22203541
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening for prostate cancer: informing men about their options.
    Mahon SM
    Clin J Oncol Nurs; 2005 Oct; 9(5):625-7. PubMed ID: 16235590
    [No Abstract]   [Full Text] [Related]  

  • 20. The United States Preventive Services Task Force recommendation against prostate-specific antigen screening--point.
    Ablin RJ
    Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):391-4. PubMed ID: 22315362
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.